Retrogenix advances medical research and speeds up drug discovery for its clients by providing a unique service which identifies specific cell surface and secreted protein interactions in human cells. Retrogenix now has research agreements with nineteen of the top twenty global pharmaceutical companies, numerous drug discovery companies and many leading academic and non-for-profit institutions around the world.
We collaborated with Retrogenix and Peak Proteins to identify target receptors for COVID-19 – read the press release.
